Targeting CD300ld to normalize the tumor microenvironment: an emerging insight in cancer immunotherapyMEDCOMMIF10.72024-06-201OAAI
Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as fi rst-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation studyECLINICALMEDICINEIF102024-06-0117OAAI
Clinical practice of transarterial chemoembolization for hepatocellular carcinoma: consensus statement from an international expert panel of International Society of Multidisciplinary Interventional Oncology (ISMIO)HEPATOBILIARY SURGERY AND NUTRITIONIF7.82021-10-0175OA
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向